Log in to save to my catalogue

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis...

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ed2f433cbfe4e318fc1e650137569fa

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma

About this item

Full title

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2021-01, Vol.6 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Although activator of HSP90 ATPase activity 1 (AHA1) is reported to be a potential oncogene, its role in osteosarcoma progression remains largely unclear. Since metabolism reprogramming is involved in tumorigenesis and cancer metastasis, the relationship...

Alternative Titles

Full title

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5ed2f433cbfe4e318fc1e650137569fa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ed2f433cbfe4e318fc1e650137569fa

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-020-00387-1

How to access this item